Biotech · Private company
Inspirna, Inc.
Track this companyFree. Adds Inspirna, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- BevacizumabPhase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- FOLFIRIPhase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- FOLFOX regimenPhase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- ompenaclidPhase 1 · Gastrointestinal CancerClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- RGX-104Phase 1 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal CancerPHASE1 · COMPLETED · started Jun 5, 2018ClinicalTrials.gov NCT03597581 · fetched Nov 12, 2026
- A Study of RGX-104 in Patients With Advanced Lung & Endometrial CancerPHASE1 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02922764 · fetched Nov 12, 2026